
iRhythm Technologies (IRTC) Stock Forecast & Price Target
iRhythm Technologies (IRTC) Analyst Ratings
Bulls say
iRhythm Holdings is well-positioned in the digital healthcare industry with its innovative Zio platform that offers more efficient and accurate diagnostic solutions for arrhythmias. The company's recent financial performance, with a revenue beat and gross margin expansion, supports our positive outlook on its growth potential and ability to achieve profitability. Additionally, the company's focus on expanding into new market segments and its strong execution in existing segments suggest continued beat-and-raise performance in the future.
Bears say
iRhythm Holdings is a company with great potential in the digital healthcare industry, but despite its strong revenue growth and profitability, we have a negative outlook on the stock. The potential risk associated with changes to risk-adjusted payment criteria from CMS could impact the company's financial performance and disrupt its growth trajectory. Additionally, the stock's high valuation and potential competition in the space could lead to limited upside for investors.
This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.
iRhythm Technologies (IRTC) Analyst Forecast & Price Prediction
Start investing in iRhythm Technologies (IRTC)
Order type
Buy in
Order amount
Est. shares
0 shares